Recent Posts

Settlements Of Class Action Securities Lawsuits Involving U.S.-Listed Chinese Companies Are Relatively Modest
Posted on 9 Jul 2012 by Kevin M. LaCroix

Beginning in 2010 and accelerating in 2011, plaintiffs' lawyers filed a wave of securities class action lawsuits against U.S.-listed Chinese companies, many of which obtained their U.S. listings via reverse merger. These cases have been making their... Read More

Tone Used In Disclosure Statements Can Affect Susceptibility To Securities Class Actions
Posted on 19 Jan 2012 by Kevin M. LaCroix

The tone public companies use in their disclosure statements can affect the companies' susceptibility to securities class action litigation, according to a recent academic study. The authors found that firms hit with securities litigation generally... Read More

New Trends In Securities Litigation Emerged In 2010, According To PwC Study
Posted on 15 Apr 2011 by Kevin M. LaCroix

A number of trends that had predominated in recent years diminished during 2010 while new trends emerged, according to PwC's 2010 Securities Litigation Study, which can be found here . 2010 may also mark "the start of a new era" as a consequences... Read More

Academics Identify Factors That Affect Outcomes Of Securities Class Action Lawsuits
Posted on 10 May 2012 by Kevin M. LaCroix

A great deal of the analysis of securities class action lawsuit settlements revolves around measures of aggregate, average and median settlement amounts. These data, while useful, are relatively unhelpful in trying to anticipate the outcome of any particular... Read More

Securities Class Action Lawsuit Filed By H-P Shareholders Over Autonomy Revelations
Posted on 30 Nov 2012 by Kevin M. LaCroix

When H-P announced on November 20, 2012 that it was taking an $8.8 billion charge after it discovered "accounting improprieties, misrepresentations and disclosure failures" at its Autonomy unit (which H-P acquired in October 2011 for $11.1 billion... Read More

Securities Class Action Lawsuits Against Life Sciences Companies Rose In 2012
Posted on 22 Mar 2013 by Kevin M. LaCroix

The number of securities class action lawsuits filed against life sciences companies rose in both absolute and relative terms in 2012, according to a March 20, 2013 memorandum by David Kotler of the Dechert law form entitled "Survey of Securities... Read More